FDA's Biggest New Policies Of 2014: Midyear Report
New rules and guidance from the U.S. Food and Drug Administration have made lots of waves with drug and device makers in 2014, sparking debate about future oversight of off-label promotion,...To view the full article, register now.
Already a subscriber? Click here to view full article